Navigation Links
Medifast Announces First Quarter 2008 Financial Results
Date:5/12/2008

and awareness generated by our direct response advertising drives business across our multi-channeled platform by fueling customers and business leads to Take Shape for Life and creating walk-ins to Medifast Weight Control Centers. The Company provides customers many options for support on our clinically proven weight loss program. The solutions that we provide to consumers dedicated to improving their quality of life have proven to be effective and we are dedicated to delivering our value proposition to the market in the most efficient and cost-effective manner possible."

Gross margins increased to 75.8% from 74.8% for the first quarter of 2008 compared with a year ago. The gross margin improved due to efficiencies gained from new machinery purchases in prior year as well as new shipping rules that resulted in additional shipping revenue from customers netting against shipping expense

2008 Full-Year Guidance

Management reiterates expectations of revenue growth for full-year 2008 in the range of 8-10%; and diluted earnings per share growth in the range of 30-35% for the year ended December 31, 2008.

First Quarter 2008 Conference Call

Interested parties can access the call by dialing (877) 407-8031 or (201) 689-8031, or can listen via a live Internet web cast, which can be found at http://www.choosemedifast.com in the section marked "Investor Relations." A replay of the call is available via web cast at http://www.choosemedifast.com until August 12, 2008 or by playback at (877) 660-6853 or (201) 612-7415 through June 12, 2008. Please use account #286 and conference id #282077 for the replay.

About Medifast:

Medifast (NYSE:

SOURCE Medifast, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Medifast Announces Year-end 2007 Financial Results
2. Medifast, Inc. to Announce Fourth Quarter and Fiscal Year-End Results on Wednesday, March 12, 2008
3. Medifast Franchise Systems Sells First Territory in Baltimore
4. Medifast Offers 5 Heart Healthy Tips in Recognition of Fridays National Wear Red Day
5. Medifast Offers Stranded Pure Weight Loss Clients Unique Options
6. Medifast Receives Notice Regarding NYSE Listing
7. Medifast, Inc. Director of Research & Development Co-Authors Health Book
8. Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008
9. Medifast, Inc. Receives Approval to Sell Medifast Weight Control Centers Franchises in Seven Additional States
10. Medifast Announces Third-Quarter 2007 Results
11. Medifast Announces Updated Full Year 2007 Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... who translate math into,better patient care and ... its,tracks are this year,s winners of the Komen ... research and clinical research. They will be hono...e Cure(R) announced today. , (Logo: http:... ) , Award recipients will be formally reco...
(Date:12/4/2008)...ST HEALTH, a six-hospital,system based in Little ... has,expanded its use of Clinical Xpert(TM) CareF...led the system,s pharmacists to increase necessary...lion. , "Data we collected for the 220-bed ...pts approximately half of the pharmacy clinical in...
(Date:12/4/2008)...t gene could ease sickle-cell disease and thalasse... 2008 -- Researchers at Children,s Hospital Boston...cer Institute have identified a way to get red blo...made only before birth or by young infants. This c... beta-thalassemia -- life-threatening inherited an...
(Date:12/4/2008)...nce and ethics online forum , , MINNEAPOLIS... Corporate Compliance and Ethics (SCCE) and the He...today the associations are making their Social Net...professionals beginning today, December 4, 2008. P...participate in the online discussions, compliance ...
Breaking Medicine News(10 mins):Health News:Susan G. Komen for the Cure(R) Announces Recipients of 2008 Komen Brinker Award for Scientific Distinction 2Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 2Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 3Health News:Turning back the Clock in Inherited Anemias 2Health News:Turning back the Clock in Inherited Anemias 3Health News:Turning back the Clock in Inherited Anemias 4Health News:SCCE and HCCA Social Network Now Open to All Compliance and Ethics Professionals 2Health News:SCCE and HCCA Social Network Now Open to All Compliance and Ethics Professionals 3
...atial processing, memory, and cognitive proficienc...s much more prevalent among alcoholics than the ge...e effects of cigarette smoking in alcoholism have ...hat long-term smoking is associated with neurocogn...
...t and Craig Greven, Vitreoretinal surgeon, Wake Fo...alignant melanoma of uvea with radiation therapy. ...curs in only six per one million people per year i... pigmented people and is rarely seen in nonwhite r...
...scription weight-loss medication orlistat (markete... to be safe, effective and tolerable in overweight...day at the 2005 Annual Meeting of NAASO, The Obesi...a. The study, which compared orlistat 60 mg plus ...
...Singh and Union Health Minister Anbumani Ramadoss ...an face the problem of bird flu epidemic. //Awaren...very less in India compared to the Western countri...ary directions to India to start getting prepared ...
Other Medicine News:Health News:Radiation therapy effective against Eye cancer 2Health News:Weight-Loss Medication Evaluated By Nutrition Expert 2
(Date:12/4/2008)...AM, December 4 Biopharmaceutical c...successfully completed treatment of the,last pati...R(TM), a donor,lymphocyte cell based product, is ...ost Disease (GvHD) and allow early immune reconsti...antation. Nineteen end stage blood cancer,patient...
(Date:12/3/2008)... N.J., Dec. 4 Roche today announce... has provided further guidance on the requirements...CTEMRA(R) (tocilizumab), the first interleukin-6 (...ied for the treatment of adult patients with moder.... , , As a result of the FDA,s evolving Ri...
(Date:12/3/2008)... Del., Dec. 3 Isogen, a contract d...rile filling, announced it has retained a,strateg...to meet the global,biopharma demand for Isogen,s ... a successful first round series of capital,inves...cility in Q1 2009 to,deliver on the previously un...
(Date:12/2/2008)..., Dec. 3 Breast-specifi...ion of cancers not found on mammograms or by,clin... the annual meeting of,the Radiological Society o...y the most difficult to detect breast cancer-invas.... Brem, M.D., professor of,radiology and director...
Breaking Medicine Technology:Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations 2Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 2Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 3Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 4Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 5Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3QLT Completes Acquisition of ForSight Newco II Inc 4106 1QLT Completes Acquisition of ForSight Newco II Inc 4106 2QLT Completes Acquisition of ForSight Newco II Inc 4106 3Congress and the President Must Act to Secure Peace of Mind for Americas Laboring Families 4101 1Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 1Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 2Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 3Exposure to sunlight may decrease risk of advanced breast cancer by half 4099 1Exposure to sunlight may decrease risk of advanced breast cancer by half 4099 2Exposure to sunlight may decrease risk of advanced breast cancer by half 4099 3
... enabled more and more laboratory testing to occur...laboratory is hardly threatened with extinction. N...labs are busier than ever before, and the huge ran...y and ability to handle very large volumes of test...the clinical landscape. , ,This is especially ...
...ding Editor Harvard Medical School , ,With hu...ted in Asia and Eastern Europe, public health offi...rveillance, diagnosis, and treatment. The virus i...ch has become epidemic in poultry and wild fowl in...ly, some humans in close contact with infected bir...
Other Medicine Technology:Immunoassay Systems - Your Laboratory Workhorse 2Avian (Bird) Flu: Is There a Role for Rapid Tests? 2Avian (Bird) Flu: Is There a Role for Rapid Tests? 3
The Estradiol (E2) Enzyme Immunoassay is intended for the for the quantitative determination of Estradiol (E2) concentration in human serum or plasma.
RIA kit for the quantitative determination of autoantibodies to thyroglobulin in serum.
...an 125I radioimmunoassay designed for,in vitro d... estradiol in serum, for the,investigation of pr...n, and for the,differential diagnosis of amenorr...tion,induction with and without stimulation in,...
Coat-A-Count Estradiol is,a no-extraction, solid-phase 125I,radioimmunoassay designed for in vitro,diagnostic use in the quantitative,measurement of estradiol in serum, for the,differential
Medicine Products: